Trials / Unknown
UnknownNCT02641665
Plasma Biomarkers in Cardiac Valve Surgery
Measurement of Four Plasma Biomarkers for Risk Stratification and Determination of Functional Recovery After Cardiac Valve Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The level of four biomarkers will be measured in the patients' plasma after induction of anaesthesia. There biomarkers are NT-ProBNP, ST2, Galectin-3 and GDF-15. The level of these marker will then be correlated with early (30 days) and late (one year) patients' prognosis and with functional recovery (MLHFQ score).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cardiac valve surgery | Aortic or mitral valve replacement/repair performed in isolation of in addition to coronary artery bypass graft(s). |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-12-01
- Completion
- 2018-12-01
- First posted
- 2015-12-29
- Last updated
- 2017-10-06
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02641665. Inclusion in this directory is not an endorsement.